BIOINSUMOSECUADOR S.A.S.– Elevating Bioproduct Manufacturing with Disc Granulation

Background

BIOINSUMOSECUADOR S.A.S., headquartered in Guayaquil, Ecuador, specializes in scientific research and the development of bioproducts. Founded on September 26, 2021, the company has rapidly expanded its operations, increasing net revenue by 28.44 % and total assets by 62.58 % in 2023

Challenge

To boost production efficiency and product consistency, BIOINSUMOSECUADOR needed a reliable solution to produce homogeneous biogeria or solid-form bio-inputs at industrial volume—ensuring uniform quality, scalability, and process control.

Solution

BIOINSUMOSECUADOR invested in a disc granulator—a proven technology for forming cohesive, high-quality granules. The disc granulator enabled precise granulation, improving particle distribution and facilitating dosing and application.

Implementation & Impact

Precision Granulation: The disc granulator produced uniform, highly consistent granules, critical for maintaining quality across large batches.

Operational Scalability & Efficiency: The automated granulation process increased output while reducing labor and variability.

Product Improvement: Enhanced flowability and stability of solid formats, improving shelf life and user experience for end customers.

Competitive Advantage: The company strengthened its position in the bioproduct market by offering scalable, premium-quality granules.

Conclusion

BIOINSUMOSECUADOR’s strategic acquisition of a disc granulator marked a leap forward in its production capabilities—aligning with its impressive financial growth and dedication to innovation and quality EMIS. This investment not only addresses immediate scalability needs but also positions the company for long-term success in delivering sustainable, high-performance bio-inputs.